• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Preanalytical considerations in drug assays in clinical pharmacokinetic studies.

作者信息

Mehta A C

机构信息

Department of Pharmacy, General Infirmary, Leeds, Yorkshire, U.K.

出版信息

J Clin Pharm Ther. 1989 Aug;14(4):285-95. doi: 10.1111/j.1365-2710.1989.tb00249.x.

DOI:10.1111/j.1365-2710.1989.tb00249.x
PMID:2677033
Abstract

Many hospital pharmacy laboratories undertake drug analysis in biological fluids for the production of pharmacokinetic data. The success of such an undertaking very much depends on the selection of a suitable analytical method and a proper approach to sample collection and handling. This paper surveys the main types of biological specimens taken from the patients for pharmacokinetic drug analysis and discusses factors that affect them during or subsequent to their removal. Guidelines are provided in specimen handling and dealing with many problems which could arise prior to actual analysis. By its very nature this paper brings in many disciplines, the full details of which are well beyond its scope, however, some discussion on pharmacokinetic and bioavailability methods in relation to sampling procedures is included to put the matter into a proper perspective.

摘要

相似文献

1
Preanalytical considerations in drug assays in clinical pharmacokinetic studies.
J Clin Pharm Ther. 1989 Aug;14(4):285-95. doi: 10.1111/j.1365-2710.1989.tb00249.x.
2
Analysis of drugs and other toxic substances in biological samples for pharmacokinetic studies.用于药代动力学研究的生物样品中药物及其他有毒物质的分析。
J Chromatogr. 1990 Oct 12;531:3-50. doi: 10.1016/s0378-4347(00)82279-3.
3
Capillary electrophoresis for pharmacokinetic studies.用于药代动力学研究的毛细管电泳
J Chromatogr B Biomed Sci Appl. 1997 Sep 12;697(1-2):67-75. doi: 10.1016/s0378-4347(97)00335-6.
4
Pharmacokinetic applications of microdevices and microsampling techniques.微型设备和微量采样技术的药代动力学应用
Bioanalysis. 2009 Apr;1(1):171-85. doi: 10.4155/bio.09.18.
5
Considerations for metabolite pharmacokinetic data in bioavailability/bioequivalence assessments. Overview of the recent trends.生物利用度/生物等效性评估中代谢物药代动力学数据的考量。近期趋势概述。
Arzneimittelforschung. 2009;59(4):155-65. doi: 10.1055/s-0031-1296380.
6
Sample collection, biobanking, and analysis.
Handb Exp Pharmacol. 2011;205:203-17. doi: 10.1007/978-3-642-20195-0_10.
7
Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management.用于人体药代动力学研究和治疗药物监测的规范化药物生物分析。
Bioanalysis. 2012 Aug;4(15):1919-31. doi: 10.4155/bio.12.157.
8
Symposium on Drug Analysis in Biological Material--Principal aspects. Stockholm, November 1-3, 1978.生物材料中药物分析研讨会——主要方面。斯德哥尔摩,1978年11月1日至3日。
Acta Pharm Suec. 1978;15(6):455-84.
9
Some considerations regarding drug determinations in biological fluids with physico-chemical methodologies [proceedings].关于采用物理化学方法测定生物体液中药物的若干思考[会议论文集]
Ann Biol Clin (Paris). 1978;36(3):161-8.
10
Bioanalytical considerations in the comparability assessment of biotherapeutics.生物治疗药物可比性评估中的生物分析考量
Bioanalysis. 2011 Mar;3(6):613-22. doi: 10.4155/bio.11.25.

引用本文的文献

1
Administration Studies in Equine Antidoping Research: Designing Scientific Investigations to Effectively Direct Medication Control in Racehorses.马类反兴奋剂研究中的管理研究:设计科学调查以有效指导赛马的药物控制
Drug Test Anal. 2025 Sep;17(9):1560-1566. doi: 10.1002/dta.3857. Epub 2025 Jan 29.